These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1513086)

  • 1. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients.
    Mak RH
    Kidney Int; 1992 Apr; 41(4):1049-54. PubMed ID: 1513086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia.
    Mak RH
    Kidney Int; 1998 May; 53(5):1353-7. PubMed ID: 9573552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin secretion and growth failure in uremia.
    Mak RH
    Pediatr Res; 1995 Sep; 38(3):379-83. PubMed ID: 7494663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin secretion in uremia: effect of parathyroid hormone and vitamin D metabolites.
    Mak RH
    Kidney Int Suppl; 1989 Nov; 27():S227-30. PubMed ID: 2699996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous calcitriol normalizes insulin sensitivity in uremic patients.
    Kautzky-Willer A; Pacini G; Barnas U; Ludvik B; Streli C; Graf H; Prager R
    Kidney Int; 1995 Jan; 47(1):200-6. PubMed ID: 7731147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-induced insulin secretion in uremia: role of 1 alpha,25(HO)2-vitamin D3.
    Allegra V; Luisetto G; Mengozzi G; Martimbianco L; Vasile A
    Nephron; 1994; 68(1):41-7. PubMed ID: 7991039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients.
    Mak RH
    Pediatr Nephrol; 1992 Jul; 6(4):345-8. PubMed ID: 1498003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid normalization/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat.
    Cade C; Norman AW
    Endocrinology; 1987 Apr; 120(4):1490-7. PubMed ID: 3549262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of parathyroid hormone in the glucose intolerance of chronic renal failure.
    Akmal M; Massry SG; Goldstein DA; Fanti P; Weisz A; DeFronzo RA
    J Clin Invest; 1985 Mar; 75(3):1037-44. PubMed ID: 3884663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating 1,25-dihydroxycholecalciferol after intravenous injections of 1 alpha-hydroxycholecalciferol in patients on regular haemodialysis.
    Papapoulos SE; vd Berg H; Frölich M; Valentijn RM
    Nephrol Dial Transplant; 1988; 3(5):647-50. PubMed ID: 3146722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
    Soliman E; Canaff L; Fox J; Hendy GN
    Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metabolic acidosis on insulin action and secretion in uremia.
    Mak RH
    Kidney Int; 1998 Aug; 54(2):603-7. PubMed ID: 9690228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays.
    Brandi L; Egfjord M; Olgaard K
    Nephron Clin Pract; 2005; 99(4):c128-37. PubMed ID: 15722644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-induced insulin secretion in uremia: effects of aminophylline infusion and glucose loads.
    Allegra V; Mengozzi G; Martimbianco L; Vasile A
    Kidney Int; 1990 Dec; 38(6):1146-50. PubMed ID: 1963648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis.
    Brandi L; Daugaard H; Tvedegaard E; Storm T; Olgaard K
    Nephron; 1989; 53(3):194-200. PubMed ID: 2797340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of parathyroid hormone infusion on glucose tolerance and glucose-stimulated insulin secretion in normal and uremic rats.
    Chen SM; Young TK; Ho LT
    Diabetes Res Clin Pract; 1998 Aug; 41(2):85-94. PubMed ID: 9789714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin, branched-chain amino acids, and growth failure in uremia.
    Mak RH
    Pediatr Nephrol; 1998 Oct; 12(8):637-42. PubMed ID: 9811385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose, insulin and glucagon response to intravenous glucose load in patients on chronic hemodialysis.
    Shasha SM; Nusem D; Kanter Y; Weiner F
    Isr J Med Sci; 1988 Jan; 24(1):15-9. PubMed ID: 3279011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.